Popular Articles

Review: Long-term Use Of Lymphoma Drug Extends Lives
A new Cochrane Library review confirms that years-long use of a drug called rituximab extends the lifespan of people with one of the milder forms of lymphoma.

Civilian Doctors, Not Just Those In Combat Settings, Urgently Need Training On Blast Injuries
The increasing incidence of terrorist attacks means that doctors in civilian settings, as well as those in combat operations, need training on blast injuries. The issues surrounding these frequently devastating injuries are discussed in a Seminar published Online First and in an upcoming edition of The Lancet, written by Dr Stephen Wolf, Department of Emergency Medicine, Denver Health Medical Center, Denver, CO, USA, and colleagues.
News of the day
AcelRx Announces Positive Phase 2 Results From A Study Of ARX-01 Sufentanil NanoTabs In Treating Post-Operative Pain
AcelRx Pharmaceuticals, Inc. announced positive results from the second Phase 2 clinical study evaluating the safety and efficacy of its ARX-01 Sufentanil NanoTabs(TM) for the management of acute post-operative pain in patients requiring opioid analgesia during hospitalization. Compared to placebo, patients receiving ARX-01 Sufentanil NanoTabs for management of post-operative pain following major abdominal surgery reported statistically significant reductions in pain intensity over the 12-hour study period.